Literature DB >> 12917318

Hypercholesterolemic aortic-valve disease.

Nalini M Rajamannan, William D Edwards, Thomas C Spelsberg.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12917318      PMCID： PMC3951872          DOI： 10.1056/NEJMc031360

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

2.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.

Authors:  C M Otto; B K Lind; D W Kitzman; B J Gersh; D S Siscovick
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245
  2 in total
  19 in total

Review 1.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 2.  Diseases of Wnt signaling.

Authors:  Mark L Johnson; Nalini Rajamannan
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

3.  Is it time for medical therapy for aortic valve disease?

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2004-11

4.  Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

Authors:  Luis M Moura; Sandra F Ramos; José L Zamorano; Isabel M Barros; Luis F Azevedo; Francisco Rocha-Gonçalves; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

5.  Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively.

Authors:  Michael Ibrahim; Ismail El-Hamamsy; Mahmoud Barbir; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2011-09-01       Impact factor: 4.132

6.  Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis.

Authors:  J Gustav Smith; Kevin Luk; Christina-Alexandra Schulz; James C Engert; Ron Do; George Hindy; Gull Rukh; Line Dufresne; Peter Almgren; David S Owens; Tamara B Harris; Gina M Peloso; Kathleen F Kerr; Quenna Wong; Albert V Smith; Matthew J Budoff; Jerome I Rotter; L Adrienne Cupples; Stephen Rich; Sekar Kathiresan; Marju Orho-Melander; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post; George Thanassoulis
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

Review 7.  Serotonin receptors and heart valve disease--it was meant 2B.

Authors:  Joshua D Hutcheson; Vincent Setola; Bryan L Roth; W David Merryman
Journal:  Pharmacol Ther       Date:  2011-04-02       Impact factor: 12.310

Review 8.  Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics.

Authors:  W David Merryman; Frederick J Schoen
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

Review 9.  Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-03

10.  Low-density lipoprotein and aortic stenosis.

Authors:  Nalini M Rajamannan
Journal:  Heart       Date:  2008-09       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.